BIOMAT Database Logo BIOMAT Database Logo

[An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis]. 1998

T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
Third Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan.

A 68-year-old woman was admitted to Kinki University Hospital because of progressive renal failure. She had been well until two months before admission. Laboratory data were as follows: serum creatinine 4.1 mg/dl, BUN 69 mg/dl, MPO-ANCA 33 EU, anti-glomerular basement membrane antibodies (AGBMA) 118 U. Histological findings showed cellular and fibrocellular crescents in many glomeruli. Therefore, we diagnosed rapidly progressive glomerulonephritis (RPGN) due to MPO-ANCA and anti-GBM associated renal disease. The patient was started on prednisolone and double filtration plasmapheresis (DFPP) therapy. Subsequently, the values of MPO-ANCA and AGBMA decreased. However, the patient's condition suddenly worsened and she died of interstitial pneumonia. Autopsy examination revealed crescentic glomerulonephritis and alveolar hemorrhage with linear deposition of IgG along the glomerular and alveolar capillary walls by immunofluorescence studies. We considered this to be a rare case of Goodpasture's syndrome associated with not only anti-GBM antibodies, but also MPO-ANCA.

UI MeSH Term Description Entries
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
[A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
March 1995, Nihon Jinzo Gakkai shi,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
[A case of anti-glomerular basement membrane antibody (AGBMA) nephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)].
June 1994, Nihon Jinzo Gakkai shi,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
August 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
Younger onset myeloperoxidase-specific antineutrophil cytoplasmic antibody- (MPO-ANCA) related glomerulonephritis accompanied with nephrotic syndrome.
October 2003, Clinical nephrology,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.
November 2007, Seminars in immunopathology,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
Propylthiouracil-associated rapidly progressive crescentic glomerulonephritis with double positive anti-glomerular basement membrane and antineutrophil cytoplasmic antibody: the first case report.
November 2015, CEN case reports,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
April 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
October 2013, Clinical and experimental nephrology,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis.
June 2005, Clinical nephrology,
T Takeda, and T Takeda, and Y Naiki, and S Yonekawa, and M Sakaguchi, and I Iwamoto, and H Tanaka, and H Hasegawa, and A Imada, and A Kanamaru, and S Hiruma, and S Maekura, and S Hashimoto, and T Yamazumi
[Rapidly progressive glomerulonephritis in a solitary kidney positive for anti-glomerular basement membrane antibodies and antineutrophil cytoplasmic antibodies].
May 1994, Casopis lekaru ceskych,
Copied contents to your clipboard!